131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat
Clinical trial NCT02035137 · COMPLETED
Trial details
- NCT number
- NCT02035137
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2021-02-26
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.